Heranba Industries Ltd

Heranba Inds Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Heranba Industries Ltd

₹ 354 1.08%
01 Dec 10:58 a.m.
heranba.co.in BSE: 543266 NSE : HERANBA
About

Incorporated in 1994, Heranba Industries Ltd is engaged in the manufacturing of a diverse range of agrochemicals such as insecticides, herbicides, fungicides and public health products for pest control. [1]

Key Points

Product Portfolio
The Co.’s portfolio comprises intermediates, technicals and formulations.
Intermediates: Intermediates manufactured are for Co.’s own captive consumption for manufacturing various Technicals and Formulations. [1] These include CMAC, Bromobenzenes, Metaphenoxy, etc.
Technicals: These include Cypermethrin, Deltamethrin, Alpha Cypermethrin, Acephate, Lambda Cyhalothrin, etc.
Formulations: Formulations and branding of formulations are a forward integration to Heranba’s technical business. These include Emulsifiable Concentrate (EC), Water Dispersible Granule (WDG), Suspension concentrate, Capsule Suspension (CS), etc.
It has 400 product registrations in 49 countries,210 registrations in pipeline in 49 countries. 24 Technicals,193 formulations are registered for manufacture & sale in India.68 technicals & 65 formulations are registered for manufacture and sale in export markets
{#https://www.bseindia.com/bseplus/AnnualReport/543266/73414543266_05_07_22.pdf#page=4 #}

Website BSE NSE
  • Market Cap ₹ 1,417 Cr.
  • Current Price ₹ 354
  • High / Low ₹ 543 / 265
  • Stock P/E 31.4
  • Book Value ₹ 207
  • Dividend Yield 0.36 %
  • ROCE %
  • ROE %
  • Face Value ₹ 10.0
Edit ratios

Pros

Cons

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Agro Chemicals Industry: Pesticides / Agrochemicals - Indian

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023
362 421 276 260 275 424
316 355 252 240 279 380
Operating Profit 46 66 24 20 -4 44
OPM % 13% 16% 9% 8% -1% 10%
4 4 1 3 6 2
Interest 1 2 2 3 2 2
Depreciation 5 6 6 6 6 6
Profit before tax 44 63 16 15 -6 38
Tax % 24% 25% 23% 24% 9% 29%
33 47 13 11 -6 27
EPS in Rs 8.35 11.78 3.16 2.79 -1.40 6.73
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2023 TTM
1,319 1,236
1,163 1,151
Operating Profit 156 85
OPM % 12% 7%
12 11
Interest 8 10
Depreciation 23 24
Profit before tax 138 63
Tax % 24%
104 45
EPS in Rs 26.08 11.28
Dividend Payout % 5%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: %
TTM: %
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: %
TTM: %
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: -35%
Return on Equity
10 Years: %
5 Years: %
3 Years: %
Last Year: %

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2023 Sep 2023
Equity Capital 40 40
Reserves 770 787
93 88
259 466
Total Liabilities 1,162 1,381
209 218
CWIP 72 165
Investments 1 1
881 997
Total Assets 1,162 1,381

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2023
0
0
0
Net Cash Flow 0

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2023
Debtor Days 107
Inventory Days 126
Days Payable 78
Cash Conversion Cycle 154
Working Capital Days 131
ROCE %

Shareholding Pattern

Numbers in percentages

Mar 2021Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023
74.15% 74.15% 74.61% 74.77% 74.77% 74.83% 74.87% 74.87% 74.90% 74.94% 74.95%
3.85% 3.27% 2.64% 2.62% 2.62% 2.27% 2.04% 1.37% 0.00% 0.00% 0.00%
4.80% 2.04% 1.58% 1.38% 1.57% 1.68% 1.45% 1.19% 1.21% 0.85% 0.29%
17.19% 20.54% 21.17% 21.22% 21.03% 21.22% 21.63% 22.56% 23.89% 24.21% 24.76%
No. of Shareholders 1,10,82697,15989,55792,12592,02994,39693,16693,33794,59693,08289,895

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

DRHP

Credit ratings

Concalls